Vanguard Group’s Clearside Biomedical CLSD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.69M | Buy |
3,363,061
+556,454
| +20% | +$445K | ﹤0.01% | 3434 |
|
2025
Q1 | $2.58M | Hold |
2,806,607
| – | – | ﹤0.01% | 3402 |
|
2024
Q4 | $2.67M | Sell |
2,806,607
-33,371
| -1% | -$31.7K | ﹤0.01% | 3480 |
|
2024
Q3 | $3.61M | Hold |
2,839,978
| – | – | ﹤0.01% | 3386 |
|
2024
Q2 | $3.69M | Buy |
2,839,978
+349,182
| +14% | +$454K | ﹤0.01% | 3379 |
|
2024
Q1 | $3.81M | Buy |
2,490,796
+314,480
| +14% | +$481K | ﹤0.01% | 3398 |
|
2023
Q4 | $2.55M | Buy |
2,176,316
+9,431
| +0.4% | +$11K | ﹤0.01% | 3515 |
|
2023
Q3 | $1.88M | Hold |
2,166,885
| – | – | ﹤0.01% | 3607 |
|
2023
Q2 | $2.43M | Hold |
2,166,885
| – | – | ﹤0.01% | 3591 |
|
2023
Q1 | $2.25M | Hold |
2,166,885
| – | – | ﹤0.01% | 3629 |
|
2022
Q4 | $2.43M | Buy |
2,166,885
+1,208
| +0.1% | +$1.35K | ﹤0.01% | 3596 |
|
2022
Q3 | $2.45M | Hold |
2,165,677
| – | – | ﹤0.01% | 3670 |
|
2022
Q2 | $3.18M | Hold |
2,165,677
| – | – | ﹤0.01% | 3599 |
|
2022
Q1 | $4.96M | Sell |
2,165,677
-9,475
| -0.4% | -$21.7K | ﹤0.01% | 3536 |
|
2021
Q4 | $5.98M | Sell |
2,175,152
-3,020
| -0.1% | -$8.31K | ﹤0.01% | 3511 |
|
2021
Q3 | $13.1M | Buy |
2,178,172
+72,082
| +3% | +$432K | ﹤0.01% | 3093 |
|
2021
Q2 | $10.3M | Buy |
2,106,090
+378,559
| +22% | +$1.84M | ﹤0.01% | 3186 |
|
2021
Q1 | $4.27M | Buy |
1,727,531
+36,790
| +2% | +$90.9K | ﹤0.01% | 3610 |
|
2020
Q4 | $4.63M | Buy |
1,690,741
+48,077
| +3% | +$132K | ﹤0.01% | 3394 |
|
2020
Q3 | $2.53M | Buy |
1,642,664
+50,568
| +3% | +$77.9K | ﹤0.01% | 3419 |
|
2020
Q2 | $2.99M | Sell |
1,592,096
-43,349
| -3% | -$81.5K | ﹤0.01% | 3315 |
|
2020
Q1 | $2.78M | Buy |
1,635,445
+575,055
| +54% | +$978K | ﹤0.01% | 3206 |
|
2019
Q4 | $3.08M | Buy |
1,060,390
+25,725
| +2% | +$74.6K | ﹤0.01% | 3329 |
|
2019
Q3 | $652K | Buy |
1,034,665
+110,180
| +12% | +$69.4K | ﹤0.01% | 3756 |
|
2019
Q2 | $899K | Buy |
924,485
+370,690
| +67% | +$360K | ﹤0.01% | 3700 |
|
2019
Q1 | $764K | Sell |
553,795
-5,810
| -1% | -$8.02K | ﹤0.01% | 3693 |
|
2018
Q4 | $598K | Sell |
559,605
-696,057
| -55% | -$744K | ﹤0.01% | 3699 |
|
2018
Q3 | $7.72M | Buy |
1,255,662
+27,178
| +2% | +$167K | ﹤0.01% | 3052 |
|
2018
Q2 | $13.1M | Buy |
1,228,484
+79,769
| +7% | +$853K | ﹤0.01% | 2767 |
|
2018
Q1 | $12.3M | Buy |
1,148,715
+376,500
| +49% | +$4.04M | ﹤0.01% | 2728 |
|
2017
Q4 | $5.41M | Buy |
772,215
+51,958
| +7% | +$364K | ﹤0.01% | 3101 |
|
2017
Q3 | $6.3M | Buy |
720,257
+18,707
| +3% | +$163K | ﹤0.01% | 3020 |
|
2017
Q2 | $6.39M | Buy |
701,550
+70,488
| +11% | +$642K | ﹤0.01% | 2994 |
|
2017
Q1 | $5.01M | Buy |
631,062
+45,657
| +8% | +$363K | ﹤0.01% | 3051 |
|
2016
Q4 | $5.23M | Buy |
585,405
+253,679
| +76% | +$2.27M | ﹤0.01% | 3045 |
|
2016
Q3 | $5.76M | Buy |
+331,726
| New | +$5.76M | ﹤0.01% | 2937 |
|